Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05229705
Other study ID # 120336
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date September 23, 2022
Est. completion date June 30, 2024

Study information

Verified date December 2023
Source Western University, Canada
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Older adults with type 2 diabetes experience neurocognitive decline and are at higher risk for developing dementia. Consequently, older adults at-risk for developing type 2 diabetes (i.e., those who are overweight and/or prediabetic) are at higher risk for neurocognitive decline, and intervening at this point may prevent or delay the onset of such decline. One promising lifestyle intervention that has been shown to improve cognitive function and brain health in other populations is resistance exercise. We previously conducted a 6-month resistance training randomized controlled trial (RCT) pilot study that showed a large scale trial would be viable and feasible. Consequently, we would like to explore resistance exercise as a lifestyle intervention to improve cognition and brain structure in older adults at risk for diabetes.


Description:

The effects of exercise on cognition and brain structure in older adults at risk for type 2 diabetes: A 3T MRI study Objectives/research questions: In this study the research questions included: 1. Does twice-weekly resistance training impact cognitive function compared to balance-and-tone exercises in older adults at risk for diabetes? 2. Can resistance training modify brain structure and volume in various brain structures, particularly the hippocampus, compared with balance-and-tone training (control) in older adults at risk for diabetes? Hypotheses: 1. 6-months of resistance training will improve cognitive function in older adults at risk for diabetes compared to balance and tone training. We predict to see significant improvements in executive function in the resistance-trained group compared with the balance-and-tone group. 2. 6-months of resistance training will preserve hippocampal structure and volume in older adults at risk for diabetes compared to balance-and-tone exercises. Design: 6-month Randomized Controlled Trial, Single Blinded Study Arms: 1) Experimental: Resistance Training (RT) 2) Control: Balance-and-Tone (BAT) Training Methodology: Screening: Participants will complete the initial screening over the phone. Interested participants will be sent the Letter of Information (via e-mail, or preferred method) to get more detailed information about the study. Those who are eligible will be scheduled to come into the lab for baseline assessments. Baseline assessments: The following questionnaires/tests/assessments will be completed. Participants can decline any or all the tests or can choose to not answer any of the questions. If they choose to not answer a question or complete a test that is necessary for confirming eligibility, they will be excluded from the rest of the study. Randomization: Once participants complete all baseline assessments, they will be randomly assigned to one of two groups using a random number generator. All participants have equal chances of getting into the 2 groups. Total time to complete baseline assessments in the lab (excluding magnetic resonance imaging; MRI) will be 2 to 2.5 hours. 1. Basic demographic questionnaire: Will be used to characterize our sample. 2. Functional Comorbidity Index (FCI): An 18-item list of diagnoses used to determine comorbidities. 3. Sleep questionnaire: Determines quality and quantity of sleep over a one-month time span and the previous night specifically. 4. Activities-Specific Balance Scale (ABC): A 16-item self-report questionnaire used to assess balance and functional mobility. Participants rate their balance confidence in their ability to perform daily activities. 5. The Lawton Instrumental Activities of Daily Living (IADL): A self-report questionnaire used to assess independent living skills. 6. Physical Activity Scale for the Elderly (PASE): Used to measure the level of self-reported physical activity, and consists of 12 questions about leisure, household, and work-related daily activity. 7. The Canadian Diabetes Risk Questionnaire (CANRISK): A 12-item self-report questionnaire used to determine if participants are at high-risk of having pre-diabetes or type II diabetes. 8. Diabetes questionnaire: A questionnaire to determine risk of diabetes. 9. Geriatric Depression scale: A 15-item questionnaire used to test for the presence of depression. If depression is suspected, the Primary Investigator (PI) will ensure that the participant is provided with a copy of the questionnaire and will advise the participant to make an appointment with their family physician to discuss the results. 10. 12-Item Short Form Survey (SF-12): Self-reported survey of health. 11. Six-minute walk test: Used to assess aerobic fitness. Participants walk at their usual speed for a total of 6 minutes in the hallway outside of our lab. The total distance walked in meters is recorded. 12. Timed Up and Go test (TUG): Used to assess mobility. Participants are seated in a chair and must stand up, walk a distance of 3 meters at their usual pace, turn around, return to their chair, and sit back down. The time to complete each of two separate trials is recorded in seconds. 13. Short Physical Performance Battery (SPPB): Used to assess gait speed, balance, and lower extremity physical function using tasks that mimic daily activities; includes three tasks: Standing Balance Task, Walking Speed Task, and Chair Stand Test. 14. Falls history: Used to assess mobility and falls-risk. 15. One-repetition maximum (1RM): A physical measure of an individual's maximum muscle strength during a single repetition and is used to determine the desired load for resistance training. Exercise includes leg press, latissimus pulldown, leg curl, chest press, bicep curls, tricep extensions, and pulley rows. 16. Paired Associative Learning (PAL) Touchscreen Task: Used to test learning and remembering of three objects that are associated with a correct spatial location on the screen. 17. Trail Unique-Non-Matching-Location (TUNL) Task: This is a working spatial memory task that involves selecting a different stimulus (non-matching) to the stimulus presented on the screen after a delay period. The stimuli are presented in locations far apart or close together to challenge spatial memory. 18. Progressive Ratio (PR) Touchscreen Task: This task tests motivation and attention and involves repeatedly touching a square stimulus at the center of the screen for points in a single trial. The number of touches required for points increases on a ramp scale, which begins at one touch and then is increased by four on each subsequent trial. If the participant stops responding for 5 minutes, the task stops, and the point of break (stopping) is recorded. 19. Mini-Mental Status Examination (MMSE): Used as a screening tool for cognitive impairment. This 11-item test assesses global cognitive function in the domains of orientation, registration, attention and calculation, recall, and language. Maximum score is 30. 20. Montreal Cognitive Assessment (MoCA): Used as a screening tool for mild cognitive impairment. This test assesses cognitive ability in the domains of attention and concentration, executive functions, memory, language, visuoconstructional skills, conceptual thinking, calculations, and orientation. Maximum score is 30. 21. Alzheimer's Disease Assessment Scale Cognitive Subscale 11 (ADAS-Cog-11): Test with 11 tasks measuring various cognitive functions (memory, language, praxis, attention). Used widely in clinical trials to assess cognitive dysfunction and Alzheimer's Disease. 22. Trail Making Test (TMT): Used to assess executive function in the areas of visual attention (Part A) and set-shifting (the ability to shift attention between one task and another; Part B). The time to complete this test is recorded in seconds. 23. Stroop: Used to assess executive function in the areas of selective attention, processing speed, and cognitive flexibility. The time to complete this test is recorded in seconds. 24. Digit Span: Used to assess working memory. Participants are required to memorize and recall a series of number lists both forward and backward. 25. Blood Tests: We will collect blood samples to test glycated hemoglobin and fasting glucose levels to determine diabetes status (pre-diabetes, diabetes) and biomarkers of brain health (brain-derived neurotrophic factor, insulin-like growth factor 1). Blood will be drawn in the exercise health lab. Blood draws will be done by registered nurse (RN) Arlene Fleischhauer in Co-investigator (Co-I) Kevin Shoemaker's lab or by our trained research student, Olivia Ghosh-Swaby. 26. Physical Activity Readiness Questionnaire (PAR-Q): The researchers will provide this form to be filled out by their family physician and returned. The form outlines the exercise program in the study to the family physician so they can advise appropriately. MRI Screening form: Used to screen for eligibility for MRI scanning. MRI scanning will be done at the Centre for Functional and Metabolic Mapping at the Robarts Research Institute. The one-hour scan will consist of the following: 1. Structural MRI 3Tesla (3T) scan (T1) to examine brain structure images to subject-specific structural images. 2. Resting-state functional connectivity to examine activation in the resting state network. Exercise intervention: Exercise classes will run two times per week for 26 weeks (6 months). Classes will be group classes, with up to 5 participants in each class. All classes will be 1 hour total - 10 minutes warm up, 40 minutes main exercises, 10 minutes cool-down. Class leaders will be present during all classes to monitor participants for shortness of breath, proper technique, and to reduce any risks/hazards during the exercise classes. This protocol has been used extensively by the PI (Liu-Ambrose et al., 2010; Liu-Ambrose et al., 2012; Nagamatsu et al., 2012; Nagamatsu et al., 2013). RESISTANCE TRAINING: Exercises will be completed in Kevin Shoemaker's exercise lab in the Health Sciences Building. Participants will use the programmable weight machines along with free weights to target primary muscle groups. In addition, they will complete mini-squats, mini-lunges, and lunge walks. Participants will complete two sets of 6-8 reps. Training stimulus will be increased using the "7-RM" method - when 2 sets of 6-8 reps are completed with proper form and without discomfort. We will record the number of sets completed and the load lifted for each exercise for each participant at every class. BALANCE AND TONE (Control): Exercises will be completed in the Health Science Exercise lab (same as above). These will include stretching exercises, range of motion exercises, basic core-strength exercises, balance exercises, and relaxation techniques. Only bodyweight will be applied (i.e., no additional loading). This group controls for confounding variables such as physical training received by traveling to the training centres, social interaction, and changes in lifestyle secondary to study participation Compliance: Class attendance will be recorded by class instructors. Adverse events: All adverse events that occur during exercise classes will be recorded and reported immediately. Fidelity Questionnaire: To ensure consistency across exercise classes and help identify any potential program issues, a questionnaire was completed by a nonstudy affiliate once per month, where he/she attended and evaluated a randomly selected RT and BAT session. Monthly assessments: During the 6-month exercise intervention, participants will complete the following assessments monthly. 1. PASE 2. Falls calendar Final assessments: All baseline assessments will be completed at trial completion (26 weeks) INCLUDING MRI scanning and blood draw with consent. Significance: This study will elucidate whether resistance exercise is a plausible intervention for cognitive decline in those at risk for diabetes. The findings of this study will also determine a viable time point to intervene before the onset of a significant decline in older adults with disrupted metabolic homeostasis. Additionally, this study has the potential to identify cost-effective and accessible strategies to improve cognitive function in those at-risk for decline. Given the enormous burden (financial, quality of life, independence) of cognitive decline in our aging society, the potential positive implications of our study cannot be overstated.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 60
Est. completion date June 30, 2024
Est. primary completion date June 30, 2024
Accepts healthy volunteers No
Gender All
Age group 60 Years to 80 Years
Eligibility Inclusion Criteria: 1. Community-dwelling 2. Aged 60-80 years 3. "At-risk" for diabetes, where they have one of the following: i) blood glucose level of 6.1-7 mmol/L, ii) body mass index > 25, or iii) score > 21 on the CANRISK diabetes questionnaire 4. Score > 24/30 on MMSE 5. Score > 6/8 on the IADL scale 6. Visual acuity of at least 20/40, with or without corrective lenses 7. Speak and understand English fluently 8. Complete the PAR-Q 9. Obtain physician's clearance to start a supervised exercise program Exclusion Criteria: 1. Current medical condition for which exercise is contraindicated 2. Participated regularly in resistance or aerobic training in the last 6 months 3. Diagnosed with neurodegenerative disease (including dementia, Alzheimer's disease, or Parkinson's disease) 4. Experienced a vascular incident (e.g., stroke, myocardial infarction) 5. Diagnosed with a psychiatric condition 6. Untreated depression and scored 5 or less on the Geriatric Depression Scale 7. Currently on hormone replacement therapy 8. Clinically significant peripheral neuropathy or severe musculoskeletal or joint disease 9. Currently taking psychotropic medications 10. Cannot blood draw

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Resistance exercise
Participants in this exercise group will receive progressive resistance training.

Locations

Country Name City State
Canada Western University London Ontario

Sponsors (1)

Lead Sponsor Collaborator
Western University, Canada

Country where clinical trial is conducted

Canada, 

References & Publications (4)

Awad N, Gagnon M, Messier C. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exp Neuropsychol. 2004 Nov;26(8):1044-80. doi: 10.1080/13803390490514875. — View Citation

Furlano JA, Nagamatsu LS. Feasibility of a 26-Week Exercise Program to Improve Brain Health in Older Adults at Risk for Type 2 Diabetes: A Pilot Study. Can J Diabetes. 2021 Aug;45(6):546-552. doi: 10.1016/j.jcjd.2020.11.001. Epub 2020 Nov 13. — View Citation

Liu-Ambrose T, Nagamatsu LS, Graf P, Beattie BL, Ashe MC, Handy TC. Resistance training and executive functions: a 12-month randomized controlled trial. Arch Intern Med. 2010 Jan 25;170(2):170-8. doi: 10.1001/archinternmed.2009.494. — View Citation

Nagamatsu LS, Handy TC, Hsu CL, Voss M, Liu-Ambrose T. Resistance training promotes cognitive and functional brain plasticity in seniors with probable mild cognitive impairment. Arch Intern Med. 2012 Apr 23;172(8):666-8. doi: 10.1001/archinternmed.2012.379. No abstract available. Erratum In: Arch Intern Med. 2013 Aug 12;173(15):1477. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Trail Making Test Used to assess executive function in the areas of visual attention (Part A) and set-shifting (the ability to shift attention between one task and another; Part B). The time to complete this test is recorded in seconds. 5 minutes
Secondary Paired Associative Learning (PAL) Touchscreen Task Used to test learning and remembering of three objects that are associated with a correct spatial location on the screen. 20 minutes
Secondary Trail Unique-Non-Matching-Location (TUNL) Task This is a working spatial memory task that involves selecting a different stimulus (non-matching) to the stimulus presented on the screen after a delay period. The stimuli are presented in locations far apart or close together to challenge spatial memory. 20 minutes
Secondary Progressive Ratio (PR) Touchscreen Task This task tests motivation and attention. The task involves touching a square stimulus at the center of the screen repeatedly for points in a single trial. The number of touches required for points increases on a ramp scale, which begins at one touch for points and then is increased by four on each subsequent trial for points. If the participant stops responding for 5 minutes, the task stops, and the point of break (stopping) is recorded. 20 minutes
Secondary Stroop Test Used to assess executive function in the areas of selective attention, processing speed, and cognitive flexibility. The time to complete this test is recorded in seconds. 5-10 minutes
Secondary Digit Span Test Used to assess working memory. Participants are required to memorize and recall a series of number lists both forward and backward. 5-10 minutes
Secondary Alzheimer's Disease Assessment Scale Cognitive Subscale 11 Test with 11 tasks measuring various cognitive functions (memory, language, praxis, attention). Used widely in clinical trials to assess cognitive dysfunction and Alzheimer's Disease. 15 minutes
Secondary Glycated hemoglobin A1c (HbA1C) We will collect blood samples to test glycated hemoglobin levels to determine diabetes status (pre-diabetes, diabetes). Blood will be drawn from a cubital vein into a 7.5 ml tube. Blood draws will be done by RN Arlene Fleischhauer in Co-I Kevin Shoemaker's lab or by trained support staff, Olivia Ghosh-Swaby. 5-10 minutes
Secondary Fasting plasma glucose We will collected via a glucometer finger prick 5-10 minutes
Secondary Height Measured in m; used to calculate body mass index (kg/m^2) 5 minutes
Secondary Weight Measured in kg; used to calculate body mass index (kg/m^2) 5 minutes
Secondary Triglyceride levels Will be assessed via serum samples measured by ELISA. 30 minutes
Secondary Inflammatory markers Will be assessed via serum samples measured by ELISA. 30 minutes
Secondary Brain-derived neurotrophic factor levels Will be assessed via serum samples measured by ELISA. 1 hour
Secondary Insulin-like growth factor levels Will be assessed via serum samples measured by ELISA. 1 hour
Secondary One repetition maximum One-repetition maximum is a physical measure of an individual's maximum muscle strength during a single repetition and is used to determine the desired load for resistance training. 10-15 minutes
Secondary Six-minute walk test Used to assess aerobic fitness. Participants walk at their usual speed for a total of 6 minutes in the hallway outside of our lab. The total distance walked in meters is recorded. 6 minutes
Secondary Short Physical Performance Battery (SPPB) - Task 1 Used to assess gait speed, balance, and lower extremity physical function using tasks that mimic daily activities; the Standing Balance Task requires participants to stand unassisted (side-by-side standing, semi-tandem standing, and tandem standing) for a period of 10 seconds each; scored in conjunction with SPPB Tasks 2 & 3 to produce one final SPPB score 5 minutes
Secondary Short Physical Performance Battery (SPPB) - Task 2 Used to assess gait speed, balance, and lower extremity physical function using tasks that mimic daily activities; the Walking Speed Task requires participants to walk 4 metres at their usual pace; measured in seconds; scored in conjunction with SPPB Tasks 1 & 3 to produce one final SPPB score 5 minutes
Secondary Short Physical Performance Battery (SPPB) - Task 3 Used to assess gait speed, balance, and lower extremity physical function using tasks that mimic daily activities; the Chair Stand Test requires participants to stand up from a chair 5 times consecutively (without the use of their arms if possible); measured in seconds; scored in conjunction with SPPB Tasks 1 & 2 to produce one final SPPB score 5 minutes
Secondary Timed Up and Go Test Used to assess mobility. Participants are seated in a chair and must stand up, walk a distance of 3 meters at their usual pace, turn around, return to their chair, and sit back down. The time to complete each of two separate trials is recorded in seconds. 5-10 minutes
See also
  Status Clinical Trial Phase
Completed NCT05712005 - Cognitive Testing in Diverse Populations to Further the Objective and Clinical Understanding of Cognivue Study
Completed NCT05343208 - Effectiveness of Online Therapy to Prevent Burnout N/A
Active, not recruiting NCT05143294 - Conectar Jugando: Board Games in Elementary Classrooms (6-12 Years Old) to Improve Executive Functions N/A
Completed NCT05267730 - Conectar Jugando: Board Games in Rural Elementary Classrooms (6-12 Years Old) to Improve Executive Functions N/A
Completed NCT03987477 - Online Intervention to Modify Interpretation Biases in Depression N/A
Completed NCT03695003 - Cognitive Effects of Sage in Healthy Humans N/A
Completed NCT05075850 - Multicenter Sub-study for LAANTERN Registry NCT02392078 That Will Include Comprehensive Neuropsychological Assessment Data Collection
Recruiting NCT05273996 - Predictors of Cognitive Outcomes in Geriatric Depression Phase 4
Completed NCT03689348 - Acute and Chronic Effects of Avena Sativa on Cognition and Stress N/A
Completed NCT03674281 - The VRIF Trial: Hypoglycemia Reduction With Automated-Insulin Delivery System N/A
Suspended NCT05001789 - Cognitive Functioning in Opioid Use Disorder N/A
Terminated NCT03337282 - Incidence and Characteristics of Postoperative Cognitive Dysfunction in Elderly Quebec Francophone Patients
Recruiting NCT05014399 - Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
Completed NCT03657537 - Effects of Ketone Bodies on Cognition in Type 2 Diabetes Phase 1
Completed NCT05543811 - The Influence of Food for Special Dietary Use - Spread Enriched With 5-hydroxytryptophan, Theanine and Gamma-aminobutyric Acid on Psychophysiological Functions of Subjects Without Meaningful Organic and Cognitive Pathology N/A
Recruiting NCT05699226 - Amplitude Titration to Improve ECT Clinical Outcomes N/A
Recruiting NCT05026541 - Resilience to Sleep Deprivation and Changes in Sleep Architecture in Shoonya Meditators N/A
Active, not recruiting NCT03255499 - Efficacy of the MovinCog Intervention in Children N/A
Not yet recruiting NCT06252376 - Effects of Blood Pressure on Cognition and Cerebral Hemodynamics in PD N/A
Recruiting NCT06099405 - Yoga Training and Retinal Vasculature N/A